PIC Therapeutics
PrivateLast Round
Series A
Oct 19, 2022
Total Funding Raised
$40M
Momentum Score
25 /100
Company Overview
PIC Therapeutics is a biotechnology company dedicated to revolutionizing cancer treatment through the development of precision-based therapeutics that target key signaling pathways to inhibit oncogene protein production.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PIC Therapeutics Comps
Public and private peers based on sector, stage, and business model.
PIC Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 19, 2022 | ||||
| Seed | Apr 15, 2020 |
Key People
Founding team and executive leadership
PIC Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Advent Life Sciences | Series A, Seed |
| OrbiMed | Series A |
| Lumira Ventures | Series A |
| Harrington Discovery Institute | Series A |
PIC Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about PIC Therapeutics's valuation, stock price, and market status.
